Shares of Alembic Pharmaceuticals Ltd were trading 4% higher on 1 April after the company announced receiving tentative approval from USFDA. In its regulatory filing,...
The US health regulator has provided its tentative approval to the pharma major Lupin for its generic version of anti-depressant Paroxetine extended-release tablets. Lupin has...